Cargando…
Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway
Myocardial ischemia/reperfusion (MI/R) injury is a common clinical problem after myocardial infarction without effective therapy. Loureirin B (LrB) is a kind of flavonoid with anti-inflammatory and antifibrotic activities. However, the effect of LrB on MI/R and its underlying mechanism remains elusi...
Autores principales: | Kong, Fei, Zhao, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078770/ https://www.ncbi.nlm.nih.gov/pubmed/35535157 http://dx.doi.org/10.1155/2022/9128210 |
Ejemplares similares
-
Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway
por: Ma, Hui, et al.
Publicado: (2022) -
Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor
por: Jiang, Yu, et al.
Publicado: (2017) -
TGF-β/Smad3 pathway enhances the cardio-protection of S1R/SIPR1 in in vitro ischemia-reperfusion myocardial cell model
por: Yang, Tingfang, et al.
Publicado: (2018) -
Estradiol Ameliorates Acute Kidney Ischemia-Reperfusion Injury by Inhibiting the TGF-βRI-SMAD Pathway
por: Ren, Lian, et al.
Publicado: (2022) -
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
por: Kawarada, Yuki, et al.
Publicado: (2016)